{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:43:03Z","timestamp":1793968983150,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Maira Khan is supported by a Nuffield Department of Population Health DPhil Prize Studentship."},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C16077\/A29186"],"award-info":[{"award-number":["C16077\/A29186"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8221\/A29017"],"award-info":[{"award-number":["C8221\/A29017"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C16077\/A29186"],"award-info":[{"award-number":["C16077\/A29186"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8221\/A29017"],"award-info":[{"award-number":["C8221\/A29017"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C16077\/A29186"],"award-info":[{"award-number":["C16077\/A29186"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,8,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We examined differences in cancer incidence between women and men and the extent to which these persisted after accounting for established risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective analyses in the UK Biobank to examine associations between sex and risk of 15 cancers (and 13 subtypes) using minimal and multivariable-adjusted Cox proportional hazards regression models. Multivariable models were stratified for age, deprivation index, and region, and adjusted for ethnicity, qualifications, height, BMI, smoking status, alcohol, and site-specific risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 10.5 (SD 2.2) years of follow-up, 32,315 incident cancers across 15 anatomical sites (58.1% in women) were identified in 470,771 individuals (53.8% women). Some differences in cancer risk between the sexes attenuated to the null in the multivariable-adjusted models, but men remained at greater risk than women for cancers at eight sites: oesophageal adenocarcinoma (hazard ratio 5.45; 95% confidence interval, 4.18\u20137.12), gastric cardia (3.65; 2.48\u20135.38), bladder (3.47; 2.85\u20134.24), oral cavity (2.06; 1.69-2.51), liver (1.91; 1.48\u20132.47), kidney (1.77; 1.51\u20132.09), rectum (1.70; 1.47\u20131.96), and leukaemia (1.43; 1.21\u20131.69). Men had lower risks for cancers of the breast, thyroid (0.36; 0.26\u20130.49), anus (0.41; 0.26\u20130.64), and lung adenocarcinoma (0.72; 0.62\u20130.84).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Further research on these sex differences in risk may provide insights into cancer aetiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03028-y","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T08:37:45Z","timestamp":1746693465000},"page":"216-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sex differences in cancer incidence: prospective analyses in the UK Biobank"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2524-5856","authenticated-orcid":false,"given":"Maira","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Papier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstin L.","family":"Pirie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2294-307X","authenticated-orcid":false,"given":"Tim J.","family":"Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth C.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"3028_CR1","unstructured":"National Cancer Registration and Analysis Service. CancerData: incidence and mortality. Available from: https:\/\/www.cancerdata.nhs.uk\/incidence_and_mortality (2023) [Accessed Oct 2024]."},{"key":"3028_CR2","unstructured":"National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/ (2023) [Accessed Oct 2024]."},{"key":"3028_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41568-021-00348-y","volume":"21","author":"S Haupt","year":"2021","unstructured":"Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Sex disparities matter in cancer development and therapy. Nat Rev Cancer. 2021;21:393\u2013407. https:\/\/doi.org\/10.1038\/s41568-021-00348-y.","journal-title":"Nat Rev Cancer"},{"key":"3028_CR4","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1055-9965.epi-08-1118","volume":"18","author":"MB Cook","year":"2009","unstructured":"Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomark Prev. 2009;18:1174\u201382. https:\/\/doi.org\/10.1158\/1055-9965.epi-08-1118.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3028_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10654-011-9647-5","volume":"27","author":"G Edgren","year":"2012","unstructured":"Edgren G, Liang L, Adami H-O, Chang ET. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27:187\u201396. https:\/\/doi.org\/10.1007\/s10654-011-9647-5.","journal-title":"Eur J Epidemiol"},{"key":"3028_CR6","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1002\/cncr.34390","volume":"128","author":"SS Jackson","year":"2022","unstructured":"Jackson SS, Marks MA, Katki HA, Cook MB, Hyun N, Freedman ND, et al. Sex disparities in the incidence of 21 cancer types: quantification of the contribution of risk factors. Cancer. 2022;128:3531\u201340. https:\/\/doi.org\/10.1002\/cncr.34390.","journal-title":"Cancer"},{"key":"3028_CR7","doi-asserted-by":"publisher","first-page":"e076962","DOI":"10.1136\/bmj-2023-076962","volume":"384","author":"J Shelton","year":"2024","unstructured":"Shelton J, Zotow E, Smith L, Johnson SA, Ahmad A, Thomson CS, et al. 25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis. BMJ. 2024;384:e076962. https:\/\/doi.org\/10.1136\/bmj-2023-076962.","journal-title":"BMJ"},{"key":"3028_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1055-9965.EPI-20-0036","volume":"29","author":"M Dong","year":"2020","unstructured":"Dong M, Gioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, et al. Sex differences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol Biomark Prev. 2020;29:1389\u201397. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0036.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3028_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5902-z","volume":"19","author":"D Zheng","year":"2019","unstructured":"Zheng D, Trynda J, Williams C, Vold JA, Ngyuyen JH, Harnois DM, et al. Sexual dimorphism in the incidence of human cancers. BMC Cancer. 2019;19:684 https:\/\/doi.org\/10.1186\/s12885-019-5902-z.","journal-title":"BMC Cancer"},{"key":"3028_CR10","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186:1026\u201334. https:\/\/doi.org\/10.1093\/aje\/kwx246.","journal-title":"Am J Epidemiol"},{"key":"3028_CR11","unstructured":"UK Biobank Coordinating Centre. UK Biobank: protocol for a large-scale prospective epidemiological resource. https:\/\/www.ukbiobank.ac.uk\/media\/gnkeyh2q\/study-rationale.pdf (2007). [Accessed May 2024]."},{"key":"3028_CR12","unstructured":"UK Biobank. UK Biobank research ethics approval. https:\/\/www.ukbiobank.ac.uk\/learn-more-about-uk-biobank\/about-us\/ethics (2021). [Accessed May 2024]."},{"key":"3028_CR13","unstructured":"UK Biobank. UK Biobank: data providers and dates of data availability. https:\/\/biobank.ndph.ox.ac.uk\/ukb\/exinfo.cgi?src=Data_providers_and_dates (2023). [Accessed May 2024]."},{"key":"3028_CR14","unstructured":"UK Biobank. UK Biobank Cancer Data: linkage from national cancer registries. https:\/\/biobank.ctsu.ox.ac.uk\/crystal\/ukb\/docs\/CancerLinkage.pdf (2023). [Accessed May 2024]."},{"key":"3028_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1200\/JCO.2009.23.8162","volume":"28","author":"WF Anderson","year":"2010","unstructured":"Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28:232\u20139. https:\/\/doi.org\/10.1200\/2FJCO.2009.23.8162.","journal-title":"J Clin Oncol"},{"key":"3028_CR16","doi-asserted-by":"publisher","unstructured":"Townsend P, Phillimore P & Beattie A. Health and deprivation (Routledge, London, 2023). https:\/\/doi.org\/10.4324\/9781003368885.","DOI":"10.4324\/9781003368885"},{"key":"3028_CR17","doi-asserted-by":"publisher","unstructured":"Adami H-O, Hunter D, Lagiou P, Mucci E. Textbook of cancer epidemiology. Vol. 1 (Oxford University Press, 2018). https:\/\/doi.org\/10.1093\/oso\/9780190676827.001.0001.","DOI":"10.1093\/oso\/9780190676827.001.0001"},{"key":"3028_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jech.46.1.12","volume":"46","author":"C La Vecchia","year":"1992","unstructured":"La Vecchia C, Negri E, D\u2019Avanzo B, Moller H, Franceschi S. Partial gastrectomy and subsequent gastric cancer risk. J Epidemiol Community Health. 1992;46:12\u20134. https:\/\/doi.org\/10.1136\/jech.46.1.12.","journal-title":"J Epidemiol Community Health"},{"key":"3028_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/annonc\/10.suppl_4.S204","volume":"10","author":"BP van Rees","year":"1999","unstructured":"van Rees BP, Tascilar M, Hruban RH, Giardiello FM, Tersmette AC, Offerhaus GJ, et al. Remote partial gastrectomy as a risk factor for pancreatic cancer: potential for preventive strategies. Ann Oncol. 1999;10:204\u20137.","journal-title":"Ann Oncol"},{"key":"3028_CR20","unstructured":"StataCorp. Stata Statistical Software: Release 18. College Station, TX: StataCorp LLC; 2023. https:\/\/www.stata.com."},{"key":"3028_CR21","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2024. https:\/\/www.R-project.org\/."},{"key":"3028_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"3028_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2019.2996","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015. JAMA Oncol. 2017;3:524 https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996.","journal-title":"JAMA Oncol"},{"key":"3028_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","volume":"84","author":"C Radkiewicz","year":"2017","unstructured":"Radkiewicz C, Johansson ALV, Dickman PW, Lambe M, Edgren G. Sex differences in cancer risk and survival: a Swedish cohort study. Eur J Cancer. 2017;84:130\u201340. https:\/\/doi.org\/10.1016\/j.ejca.2017.07.013.","journal-title":"Eur J Cancer"},{"key":"3028_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.annonc.2020.02.010","volume":"31","author":"BC Fu","year":"2020","unstructured":"Fu BC, Song M, Li X, Han J, Adami H-O, Giovannucci EL, et al. Height as a mediator of sex differences in cancer risk. Ann Oncol. 2020;31:634\u201340. https:\/\/doi.org\/10.1016\/j.annonc.2020.02.010.","journal-title":"Ann Oncol"},{"key":"3028_CR26","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s10552-014-0476-1","volume":"25","author":"GC Kabat","year":"2014","unstructured":"Kabat GC, Kim MY, Hollenbeck AR, Rohan TE. Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP Diet and Health Study. Cancer Causes Control. 2014;25:1697\u2013706. https:\/\/doi.org\/10.1007\/s10552-014-0476-1.","journal-title":"Cancer Causes Control"},{"key":"3028_CR27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jgh.14917","volume":"35","author":"J Tian","year":"2020","unstructured":"Tian J, Zuo C, Liu G, Che P, Li G, Li X, et al. Cumulative evidence for the relationship between body mass index and the risk of esophageal cancer: an updated meta\u2010analysis with evidence from 25 observational studies. J Gastroenterol Hepatol. 2020;35:730\u201343. https:\/\/doi.org\/10.1111\/jgh.14917.","journal-title":"J Gastroenterol Hepatol"},{"key":"3028_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.surg.2015.04.034","volume":"159","author":"BF Nadaleto","year":"2016","unstructured":"Nadaleto BF, Herbella FAM, Patti MG. Gastroesophageal reflux disease in the obese: pathophysiology and treatment. Surgery. 2016;159:475\u201386. https:\/\/doi.org\/10.1016\/j.surg.2015.04.034.","journal-title":"Surgery"},{"key":"3028_CR29","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1016\/j.ejca.2009.09.001","volume":"45","author":"E Chandanos","year":"2009","unstructured":"Chandanos E, Lagergren J. The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer. 2009;45:3149\u201355. https:\/\/doi.org\/10.1016\/j.ejca.2009.09.001.","journal-title":"Eur J Cancer"},{"key":"3028_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ccell.2023.05.010","volume":"41","author":"M Rask-Andersen","year":"2023","unstructured":"Rask-Andersen M, Ivansson E, H\u00f6glund J, Ek WE, Karlsson T, Johansson A. Adiposity and sex-specific cancer risk. Cancer Cell. 2023;41:1186\u201397.e4. https:\/\/doi.org\/10.1016\/j.ccell.2023.05.010.","journal-title":"Cancer Cell"},{"key":"3028_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41416-021-01575-8","volume":"126","author":"S-H Xie","year":"2022","unstructured":"Xie S-H, Santoni G, Lagergren J. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study. Br J Cancer. 2022;126:129\u201333. https:\/\/doi.org\/10.1038\/s41416-021-01575-8.","journal-title":"Br J Cancer"},{"key":"3028_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41585-022-00591-4","volume":"19","author":"D Theodorescu","year":"2022","unstructured":"Theodorescu D, Li Z, Li X. Sex differences in bladder cancer: emerging data and call to action. Nat Rev Urol. 2022;19:447\u20139. https:\/\/doi.org\/10.1038\/s41585-022-00591-4.","journal-title":"Nat Rev Urol"},{"key":"3028_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84:176\u201390. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.029.","journal-title":"Eur Urol"},{"key":"3028_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/0284186x.2018.1518591","volume":"58","author":"K Hadkhale","year":"2019","unstructured":"Hadkhale K, Martinsen JI, Weiderpass E, Kj\u00e6rheim K, Spar\u00e9n P, Tryggvad\u00f3ttir L, et al. Occupational variation in bladder cancer in nordic males adjusted with approximated smoking prevalence. Acta Oncol (Madr). 2019;58:29\u201337. https:\/\/doi.org\/10.1080\/0284186x.2018.1518591.","journal-title":"Acta Oncol (Madr)"},{"key":"3028_CR35","unstructured":"International Agency for Research on Cancer. IARC monographs on the identification of carcinogenic hazards to humans: classifications by cancer site. IARC, World Health Organization https:\/\/monographs.iarc.who.int\/wp-content\/uploads\/2019\/07\/Classifications_by_cancer_site.pdf (2019). [Accessed September 2024]."},{"key":"3028_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/aje\/kwj028","volume":"163","author":"M McGrath","year":"2006","unstructured":"McGrath M, Michaud DS, De Vivo I. Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol. 2006;163:236\u201344. https:\/\/doi.org\/10.1093\/aje\/kwj028.","journal-title":"Am J Epidemiol"},{"key":"3028_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng.2966","volume":"46","author":"LA Forsberg","year":"2014","unstructured":"Forsberg LA, Rasi C, Malmqvist N, Davies H, Pasupulati S, Pakalapati G, et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet. 2014;46:624\u20138. https:\/\/doi.org\/10.1038\/ng.2966.","journal-title":"Nat Genet"},{"key":"3028_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ng.3726","volume":"49","author":"A Dunford","year":"2017","unstructured":"Dunford A, Weinstock DM, Savova V, Schumacher SE, Cleary JP, Yoda A, et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat Genet. 2017;49:10\u201316. https:\/\/doi.org\/10.1038\/ng.3726.","journal-title":"Nat Genet"},{"key":"3028_CR39","doi-asserted-by":"publisher","first-page":"e002861","DOI":"10.1136\/bmjopen-2013-002861","volume":"3","author":"G Lyratzopoulos","year":"2013","unstructured":"Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open. 2013;3:e002861 https:\/\/doi.org\/10.1136\/bmjopen-2013-002861.","journal-title":"BMJ Open"},{"key":"3028_CR40","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","volume":"118","author":"KF Brown","year":"2018","unstructured":"Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118:1130\u201341. https:\/\/doi.org\/10.1038\/s41416-018-0029-6.","journal-title":"Br J Cancer"},{"key":"3028_CR41","unstructured":"Leeman D, Arnold S, Clarke E, Costella A, Ijaz S, Lyons S. et al. Hepatitis B in England 2024. UK Government https:\/\/www.gov.uk\/government\/publications\/hepatitis-b-in-england\/hepatitis-b-in-england-2024#foreword (2024). [Accessed September 2024]."},{"key":"3028_CR42","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"key":"3028_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08760-1","volume":"21","author":"B Xia","year":"2021","unstructured":"Xia B, Peng J, Enrico DT, Lu K, Cheung EC, Kuo Z, et al. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study. BMC Cancer. 2021;21:1084 https:\/\/doi.org\/10.1186\/s12885-021-08760-1.","journal-title":"BMC Cancer"},{"key":"3028_CR44","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.euf.2017.01.006","volume":"4","author":"G Scelo","year":"2018","unstructured":"Scelo G, Li P, Chanudet E, Muller DC. Variability of sex disparities in cancer incidence over 30 years: the striking case of kidney cancer. Eur Urol Focus. 2018;4:586\u201390. https:\/\/doi.org\/10.1016\/j.euf.2017.01.006.","journal-title":"Eur Urol Focus"},{"key":"3028_CR45","doi-asserted-by":"publisher","unstructured":"Peired AJ, Campi R, Angelotti ML, Antonelli G, Conte C, Lazzeri E, et al. Sex and gender differences in kidney cancer: clinical and experimental evidence. Cancers 13 (2021). https:\/\/doi.org\/10.3390\/cancers13184588.","DOI":"10.3390\/cancers13184588"},{"key":"3028_CR46","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrurol.2015.232","volume":"12","author":"I Lucca","year":"2015","unstructured":"Lucca I, Klatte T, Fajkovic H, de Martino M, Shariat SF. Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol. 2015;12:585\u201392. https:\/\/doi.org\/10.1038\/nrurol.2015.232.","journal-title":"Nat Rev Urol"},{"key":"3028_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.eururo.2011.10.007","volume":"61","author":"AR Brannon","year":"2012","unstructured":"Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, et al. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. Eur Urol. 2012;61:258\u201368. https:\/\/doi.org\/10.1016\/j.eururo.2011.10.007.","journal-title":"Eur Urol"},{"key":"3028_CR48","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41431-019-0455-9","volume":"27","author":"RS Laskar","year":"2019","unstructured":"Laskar RS, Muller DC, Li P, Machiela MJ, Ye Y, Gaborieau V, et al. Sex specific associations in genome-wide association analysis of renal cell carcinoma. Eur J Hum Genet. 2019;27:1589\u201398. https:\/\/doi.org\/10.1038\/s41431-019-0455-9.","journal-title":"Eur J Hum Genet"},{"key":"3028_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4786-7","volume":"18","author":"A White","year":"2018","unstructured":"White A, Ironmonger L, Steele RJC, Ormiston-Smith N, Crawford C, Seims A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018;18:906 https:\/\/doi.org\/10.1186\/s12885-018-4786-7.","journal-title":"BMC Cancer"},{"key":"3028_CR50","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/jnci\/djq444","volume":"102","author":"JH Lin","year":"2010","unstructured":"Lin JH, Giovannucci E. Sex hormones and colorectal cancer: what have we learned so far? JNCI. 2010;102:1746\u20137. https:\/\/doi.org\/10.1093\/jnci\/djq444.","journal-title":"JNCI"},{"key":"3028_CR51","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa1715907","volume":"378","author":"A Jemal","year":"2018","unstructured":"Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, et al. Higher lung cancer incidence in young women than young men in the United States. NEJM. 2018;378:1999\u20132009. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1715907.","journal-title":"NEJM"},{"key":"3028_CR52","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.3390\/cancers15123111","volume":"15","author":"L May","year":"2023","unstructured":"May L, Shows K, Nana-Sinkam P, Li H, Landry JW. Sex differences in lung cancer. Cancers. 2023;15:3111. https:\/\/doi.org\/10.3390\/2Fcancers15123111.","journal-title":"Cancers"},{"key":"3028_CR53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s1470-2045(08)70154-2","volume":"9","author":"ND Freedman","year":"2008","unstructured":"Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008;9:649\u201356. https:\/\/doi.org\/10.1016\/s1470-2045(08)70154-2.","journal-title":"Lancet Oncol"},{"key":"3028_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ijc.30084","volume":"139","author":"K Pirie","year":"2016","unstructured":"Pirie K, Peto R, Green J, Reeves GK, Beral V. Lung cancer in never smokers in the UK million women study. Int J Cancer. 2016;139:347\u201354. https:\/\/doi.org\/10.1002\/ijc.30084.","journal-title":"Int J Cancer"},{"key":"3028_CR55","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2016.04.001","volume":"29","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Liu L, Chen H, Wang Y, Xu Y, Mao H, et al. Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell. 2016;29:711\u201322. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.001.","journal-title":"Cancer Cell"},{"key":"3028_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2023.100472","volume":"31","author":"Q-L Tran","year":"2023","unstructured":"Tran Q-L, Davies L. Thyroid cancer incidence differences between men and women. Curr Opin Endocr Metab Res. 2023;31:100472 https:\/\/doi.org\/10.1016\/j.coemr.2023.100472.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"3028_CR57","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jamainternmed.2021.4804","volume":"181","author":"K LeClair","year":"2021","unstructured":"LeClair K, Bell KJL, Furuya-Kanmori L, Doi SA, Francis DO, Davies L. Evaluation of gender inequity in thyroid cancer diagnosis. JAMA Intern Med. 2021;181:1351. https:\/\/doi.org\/10.1001\/jamainternmed.2021.4804.","journal-title":"JAMA Intern Med"},{"key":"3028_CR58","doi-asserted-by":"publisher","first-page":"e29177","DOI":"10.1371\/journal.pone.0029177","volume":"7","author":"E Peterson","year":"2012","unstructured":"Peterson E, De P, Nuttall R. BMI, Diet and Female Reproductive Factors as Risks for Thyroid Cancer: A Systematic Review. PLoS One. 2012;7:e29177. https:\/\/doi.org\/10.1371\/journal.pone.0029177.","journal-title":"PLoS One"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03028-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:42:57Z","timestamp":1781847777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03028-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8,10]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03028-y","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee (UK) (reference number 06\/MRE08\/65). At recruitment, all participants gave informed consent to participate and for their health to be followed-up through linkage to their health-related records. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}